These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 23336597

  • 1. Novel Nanodimension artificial red blood cells that act as O2 and CO2 carrier with enhanced antioxidant activity: PLA-PEG nanoencapsulated PolySFHb-superoxide dismutase-catalase-carbonic anhydrase.
    Gao W, Bian Y, Chang TM.
    Artif Cells Nanomed Biotechnol; 2013 Aug; 41(4):232-9. PubMed ID: 23336597
    [Abstract] [Full Text] [Related]

  • 2. A novel nanobiotherapeutic poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] with no cardiac toxicity for the resuscitation of a rat model with 90 minutes of sustained severe hemorrhagic shock with loss of 2/3 blood volume.
    Bian Y, Chang TM.
    Artif Cells Nanomed Biotechnol; 2015 Feb; 43(1):1-9. PubMed ID: 25297052
    [Abstract] [Full Text] [Related]

  • 3. Lowering of elevated tissue PCO2 in a hemorrhagic shock rat model after reinfusion of a novel nanobiotechnological polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase that is an oxygen and a carbon dioxide carrier with enhanced antioxidant properties.
    Bian Y, Wei G, Chang TM.
    Artif Cells Nanomed Biotechnol; 2013 Feb; 41(1):60-8. PubMed ID: 23347056
    [Abstract] [Full Text] [Related]

  • 4. Polyhemoglobin-superoxide dismutase-catalase-carbonic anhydrase: a novel biotechnology-based blood substitute that transports both oxygen and carbon dioxide and also acts as an antioxidant.
    Bian Y, Rong Z, Chang TM.
    Artif Cells Blood Substit Immobil Biotechnol; 2011 Jun; 39(3):127-36. PubMed ID: 21574914
    [Abstract] [Full Text] [Related]

  • 5. Temperature stability of Poly-[hemoglobin-superoxide dismutase-catalase-carbonic anhydrase] in the form of a solution or in the lyophilized form during storage at -80 °C, 4 °C, 25 °C and 37 °C or pasteurization at 70 °C.
    Bian YZ, Guo C, Chang TM.
    Artif Cells Nanomed Biotechnol; 2016 Jun; 44(1):41-7. PubMed ID: 26613265
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Long term safety and immunological effects of a nanobiotherapeutic, bovine poly-[hemoglobin-catalase-superoxide dismutase-carbonic anhydrase], after four weekly 5% blood volume top-loading followed by a challenge of 30% exchange transfusion.
    Guo C, Chang TMS.
    Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1349-1363. PubMed ID: 29873524
    [Abstract] [Full Text] [Related]

  • 8. From artificial red blood cells, oxygen carriers, and oxygen therapeutics to artificial cells, nanomedicine, and beyond.
    Chang TM.
    Artif Cells Blood Substit Immobil Biotechnol; 2012 Jun; 40(3):197-9. PubMed ID: 22409281
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Protection of Enzyme Activity for the Preparation of Humanized Polymerized Hemoglobin-Superoxide Dismutase-Catalase-Carbonic Anhydrase.
    Wang Y, Wang W, Zhang L, Chen G.
    Dokl Biochem Biophys; 2024 Jun; 516(1):73-82. PubMed ID: 38539011
    [Abstract] [Full Text] [Related]

  • 11. Polyhemoglobin-superoxide dismutase-catalase as a blood substitute with antioxidant properties.
    D'Agnillo F, Chang TM.
    Nat Biotechnol; 1998 Jul; 16(7):667-71. PubMed ID: 9661202
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nanobiotechnological basis of an oxygen carrier with enhanced carbonic anhydrase for CO2 transport and enhanced catalase and superoxide dismutase for antioxidant function.
    Bian Y, Chang TMS.
    Front Bioeng Biotechnol; 2023 Jul; 11():1188399. PubMed ID: 37122869
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Blood replacement with nanobiotechnologically engineered hemoglobin and hemoglobin nanocapsules.
    Chang TM.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010 Jul; 2(4):418-30. PubMed ID: 20564467
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nanobiotechnological modification of hemoglobin and enzymes from this laboratory.
    Chang TM.
    Biochim Biophys Acta; 2008 Oct; 1784(10):1435-40. PubMed ID: 18565337
    [Abstract] [Full Text] [Related]

  • 20. In vitro macrophage uptake and in vivo biodistribution of PLA-PEG nanoparticles loaded with hemoglobin as blood substitutes: effect of PEG content.
    Sheng Y, Yuan Y, Liu C, Tao X, Shan X, Xu F.
    J Mater Sci Mater Med; 2009 Sep; 20(9):1881-91. PubMed ID: 19365612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.